Table of Contents

2018-2023 Global Anthim Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Anthim Consumption 2013-2023
  • 2.1.2 Anthim Consumption CAGR by Region
• 2.2 Anthim Segment by Type
  • 2.2.1 Adult
  • 2.2.2 Children
• 2.3 Anthim Consumption by Type
  • 2.3.1 Global Anthim Consumption Market Share by Type (2013-2018)
  • 2.3.2 Global Anthim Revenue and Market Share by Type (2013-2018)
  • 2.3.3 Global Anthim Sale Price by Type (2013-2018)
• 2.4 Anthim Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Drugs Store
  • 2.4.3 Other
• 2.5 Anthim Consumption by Application
  • 2.5.1 Global Anthim Consumption Market Share by Application (2013-2018)
  • 2.5.2 Global Anthim Value and Market Share by Application (2013-2018)
  • 2.5.3 Global Anthim Sale Price by Application (2013-2018)

3 Global Anthim by Players

• 3.1 Global Anthim Sales Market Share by Players
  • 3.1.1 Global Anthim Sales by Players (2016-2018)
  • 3.1.2 Global Anthim Sales Market Share by Players (2016-2018)
• 3.2 Global Anthim Revenue Market Share by Players
  • 3.2.1 Global Anthim Revenue by Players (2016-2018)
  • 3.2.2 Global Anthim Revenue Market Share by Players (2016-2018)
• 3.3 Global Anthim Sale Price by Players
• 3.4 Global Anthim Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Anthim Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Anthim Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Anthim by Regions

• 4.1 Anthim by Regions
  • 4.1.1 Global Anthim Consumption by Regions
  • 4.1.2 Global Anthim Value by Regions
• 4.2 Americas Anthim Consumption Growth
• 4.3 APAC Anthim Consumption Growth
• 4.4 Europe Anthim Consumption Growth
• 4.5 Middle East & Africa Anthim Consumption Growth

5 Americas

• 5.1 Americas Anthim Consumption by Countries
  • 5.1.1 Americas Anthim Consumption by Countries (2013-2018)
  • 5.1.2 Americas Anthim Value by Countries (2013-2018)
• 5.2 Americas Anthim Consumption by Type
• 5.3 Americas Anthim Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Anthim Consumption by Countries
  • 6.1.1 APAC Anthim Consumption by Countries (2013-2018)
  • 6.1.2 APAC Anthim Value by Countries (2013-2018)
• 6.2 APAC Anthim Consumption by Type
• 6.3 APAC Anthim Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Anthim by Countries
  • 7.1.1 Europe Anthim Consumption by Countries (2013-2018)
  • 7.1.2 Europe Anthim Value by Countries (2013-2018)
• 7.2 Europe Anthim Consumption by Type
• 7.3 Europe Anthim Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Anthim by Countries
  • 8.1.1 Middle East & Africa Anthim Consumption by Countries (2013-2018)
  • 8.1.2 Middle East & Africa Anthim Value by Countries (2013-2018)
• 8.2 Middle East & Africa Anthim Consumption by Type
• 8.3 Middle East & Africa Anthim Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Anthim Distributors
• 10.3 Anthim Customer

11 Global Anthim Market Forecast

• 11.1 Global Anthim Consumption Forecast (2018-2023)
• 11.2 Global Anthim Forecast by Regions
  • 11.2.1 Global Anthim Forecast by Regions (2018-2023)
  • 11.2.2 Global Anthim Value Forecast by Regions (2018-2023)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Anthim Forecast by Type
• 11.8 Global Anthim Forecast by Application

12 Key Players Analysis

• 12.1 Elusys Therapeutics
  • 12.1.1 Company Details
  • 12.1.2 Anthim Product Offered
  • 12.1.3 Elusys Therapeutics Anthim Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.1.4 Main Business Overview
  • 12.1.5 Elusys Therapeutics News

...

13 Research Findings and Conclusion

ANTHIM® (obiltoxaximab) is indicated in adult and pediatric patients for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs

According to this study, over the next five years the Anthim market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Anthim business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Anthim market by product type, application, key manufacturers and key regions and countries.

This study considers the Anthim value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Adult
Children
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drugs Store
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Elusys Therapeutics
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Anthim consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Anthim market by identifying its various subsegments.
Focuses on the key global Anthim manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anthim with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anthim submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.